Viatris Announces Positive Top-Line Results from Phase 3 Study of VR-205 in Japanese Adults with Primary Immunoglobulin A Nephropathy
This document is a Japanese translation of the news release distributed by Viatris Inc. on June 29, … · 2026-06-30
Viatris News Releases
Mental Health Awareness Website 'Kokoro no Hidamari' Renewed with Expanded New Content on Generalized Anxiety Disorder (GAD)
Viatris Pharmaceuticals has renewed its mental health website, 'Kokoro no Hidamari,' expanding conte… · 2026-04-08
Viatris Pharmaceutical Launches Website for School Personnel Following Administrative Notice on Administration of "Spydia® Nasal Spray" During Epileptic Seizures in Schools
Viatris Pharmaceutical G.K. has launched a website for school personnel following an administrative … · 2026-05-07
Mental Health Awareness Website 'Kokoro no Hidamari' Renewed with Expanded New Content on Generalized Anxiety Disorder (GAD)
Viatris Pharmaceuticals has renewed its mental health website, 'Kokoro no Hidamari,' expanding conte… · 2026-04-08
Viatris Pharmaceuticals Co-Hosts Public Lecture on Generalized Anxiety Disorder (GAD): 'Worried? It Might Be GAD' at the 3rd Annual Meeting of the Japanese Society of Outpatient Psychiatry, June 20 in Yokohama
Viatris Pharmaceuticals, together with the 3rd Annual Meeting of the Japanese Society of Outpatient … · 2026-06-08
Viatris and Ubie Launch Disease Awareness Project to Support Early Detection and Proper Treatment of Generalized Anxiety Disorder (GAD)
Viatris Japan and Ubie have launched a collaborative project using the 'Ubie' AI platform to increas… · 2026-05-28
Viatris Pharmaceuticals Launches First CSR Activity: 'Healthcare x Art' Mental Health Class for Youth on May 20
維亞特里斯製藥啟動首波企業社會責任活動，將於5月20日在新渡戶文化學園舉辦結合醫療與藝術的心理健康特別課程。 · 2026-05-14
Japan Society of Anxiety Disorders and Viatris Pharmaceutical Conclude Partnership Agreement for Generalized Anxiety Disorder (GAD) Disease Awareness
The Japan Society of Anxiety Disorders and Viatris Pharmaceutical have concluded a partnership agree… · 2026-05-08
Viatris Pharmaceuticals Opens Website for School Personnel Following Administrative Notice on Administering "Spydia® Nasal Spray" for Epileptic Seizures in Schools
Viatris Pharmaceuticals has launched a website for school personnel after an administrative notice w… · 2026-05-07
Mental Health Awareness Website 'Kokoro no Hidamari' Renewed with Expanded New Content on Generalized Anxiety Disorder (GAD)
Viatris Pharmaceuticals has renewed its mental health website, 'Kokoro no Hidamari,' expanding conte… · 2026-04-08
Japan Society of Anxiety Disorders and Viatris Pharmaceutical Conclude Partnership Agreement for Generalized Anxiety Disorder (GAD) Disease Awareness
The Japan Society of Anxiety Disorders and Viatris Pharmaceutical have concluded a partnership agree… · 2026-05-08
Viatris Pharmaceuticals Launches First CSR Activity: 'Healthcare x Art' Mental Health Class for Youth on May 20
Viatris Pharmaceuticals Japan announced its first CSR initiative focusing on youth mental health. On… · 2026-05-14